Sphera Funds Management »

Olema Pharmaceuticals shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 100k 14.91
2020-12-31 $731k 15k 48.09

More positions owned by Sphera Funds Management

Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tower Semiconductor Shs New (TSEM)
Spdr Series Trust State Street Spd Put Option (XBI)
NOVA MEASURING Instruments L (NVMI)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Biogen Idec (BIIB)
Ultragenyx Pharmaceutical (RARE)
Syndax Pharmaceuticals (SNDX)
Cogent Biosciences (COGT)
Sanofi Sa Sponsored Adr (SNY)
Astrazeneca Ord (AZN)
Amicus Therapeutics (FOLD)
Cellebrite Di Ordinary Shares (CLBT)

View all positions for Sphera Funds Management

Top funds holding Olema Pharmaceuticals

Paradigm Biocapital Advisors
Bain Capital Life Sciences Investors
Henderson Group
BlackRock
BVF
FMR
Cormorant Asset Management
Vanguard Group
Siren
Logos Global Management
Vanguard Capital Management
RA Capital Management
State Street Corporation
Jennison Associates
Geode Capital Management

View all funds holding Olema Pharmaceuticals